Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-12-056604
Filing Date
2012-02-13
Accepted
2012-02-13 17:05:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G d296602dsc13ga.htm SC 13G/A 40604
  Complete submission text file 0001193125-12-056604.txt   41808
Mailing Address 1207 17TH AVENUE SUITE 103 NASHVILLE TN 37212
Business Address
KAZIMI A J (Filed by) CIK: 0001075050 (see all company filings)

Type: SC 13G/A

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-85205 | Film No.: 12600127
SIC: 2834 Pharmaceutical Preparations